Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

HNF-1β in ovarian carcinomas with serous and clear cell change.

DeLair D, Han G, Irving JA, Leung S, Ewanowich CA, Longacre TA, Gilks CB, Soslow RA.

Int J Gynecol Pathol. 2013 Nov;32(6):541-6. doi: 10.1097/PGP.0b013e318273fd07.

2.

The Application Value of HNF-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma.

Huang W, Cheng X, Ji J, Zhang J, Li Q.

Int J Gynecol Pathol. 2016 Jan;35(1):66-71. doi: 10.1097/PGP.0000000000000213.

PMID:
26166716
3.

Utility of hepatocyte nuclear factor-1β as a diagnostic marker in ovarian carcinomas with clear cells.

Kao YC, Lin MC, Lin WC, Jeng YM, Mao TL.

Histopathology. 2012 Nov;61(5):760-8. doi: 10.1111/j.1365-2559.2012.04267.x. Epub 2012 Jul 2.

PMID:
22747504
4.

Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1β and oestrogen receptor.

Hoang LN, Han G, McConechy M, Lau S, Chow C, Gilks CB, Huntsman DG, Köbel M, Lee CH.

Histopathology. 2014 Mar;64(4):585-96. doi: 10.1111/his.12286. Epub 2013 Dec 7.

PMID:
24103020
5.

[Diagnostic value of combined detection of HNF-1β and Napsin A in the diagnosis of ovarian clear cell carcinoma].

Wang J, Li Q, Cheng X, Xiong K, Qi Q, Huang W.

Zhonghua Bing Li Xue Za Zhi. 2015 Dec;44(12):874-8. Chinese.

PMID:
26888504
6.

Specific expression of hepatocyte nuclear factor-1beta in the ovarian clear cell adenocarcinoma and its application to cytological diagnosis.

Higashiguchi A, Yamada T, Susumu N, Mori T, Suzuki A, Aoki D, Sakamoto M.

Cancer Sci. 2007 Mar;98(3):387-91.

7.

Clinicopathologic Significance of HNF-1β, AIRD1A, and PIK3CA Expression in Ovarian Clear Cell Carcinoma: A Tissue Microarray Study of 130 Cases.

Ye S, Yang J, You Y, Cao D, Huang H, Wu M, Chen J, Lang J, Shen K.

Medicine (Baltimore). 2016 Mar;95(9):e3003. doi: 10.1097/MD.0000000000003003.

8.

Hepatocyte nuclear factor-1β (HNF-1β) promotes glucose uptake and glycolytic activity in ovarian clear cell carcinoma.

Okamoto T, Mandai M, Matsumura N, Yamaguchi K, Kondoh H, Amano Y, Baba T, Hamanishi J, Abiko K, Kosaka K, Murphy SK, Mori S, Konishi I.

Mol Carcinog. 2015 Jan;54(1):35-49. doi: 10.1002/mc.22072. Epub 2013 Sep 17.

PMID:
24105991
9.

Diagnostic value of dual detection of hepatocyte nuclear factor 1 beta (HNF-1β) and napsin A for diagnosing ovarian clear cell carcinoma.

Li Q, Zeng X, Cheng X, Zhang J, Ji J, Wang J, Xiong K, Qi Q, Huang W.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8305-10. eCollection 2015.

10.

Immunocytochemistry for hepatocyte nuclear factor-1beta (HNF-1beta): a marker for ovarian clear cell carcinoma.

Kato N, Toukairin M, Asanuma I, Motoyama T.

Diagn Cytopathol. 2007 Apr;35(4):193-7.

PMID:
17351940
11.
12.

Endometrial Carcinomas With Clear Cells: A Study of a Heterogeneous Group of Tumors Including Interobserver Variability, Mutation Analysis, and Immunohistochemistry With HNF-1β.

Han G, Soslow RA, Wethington S, Levine DA, Bogomolniy F, Clement PB, Köbel M, Gilks B, DeLair D.

Int J Gynecol Pathol. 2015 Jul;34(4):323-33. doi: 10.1097/PGP.0000000000000162.

PMID:
25851704
13.

Global miRNA expression analysis of serous and clear cell ovarian carcinomas identifies differentially expressed miRNAs including miR-200c-3p as a prognostic marker.

Vilming Elgaaen B, Olstad OK, Haug KB, Brusletto B, Sandvik L, Staff AC, Gautvik KM, Davidson B.

BMC Cancer. 2014 Feb 11;14:80. doi: 10.1186/1471-2407-14-80.

14.

Hypomethylation of hepatocyte nuclear factor-1beta (HNF-1beta) CpG island in clear cell carcinoma of the ovary.

Kato N, Tamura G, Motoyama T.

Virchows Arch. 2008 Feb;452(2):175-80. Epub 2007 Dec 8.

PMID:
18066692
15.

Transcriptional upregulation of HNF-1β by NF-κB in ovarian clear cell carcinoma modulates susceptibility to apoptosis through alteration in bcl-2 expression.

Suzuki E, Kajita S, Takahashi H, Matsumoto T, Tsuruta T, Saegusa M.

Lab Invest. 2015 Aug;95(8):962-72. doi: 10.1038/labinvest.2015.73. Epub 2015 Jun 1.

16.

Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases.

Han G, Gilks CB, Leung S, Ewanowich CA, Irving JA, Longacre TA, Soslow RA.

Am J Surg Pathol. 2008 Jul;32(7):955-64. doi: 10.1097/PAS.0b013e318164edf7.

PMID:
18460981
17.

Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian Study.

Vang R, Levine DA, Soslow RA, Zaloudek C, Shih IeM, Kurman RJ.

Int J Gynecol Pathol. 2016 Jan;35(1):48-55. doi: 10.1097/PGP.0000000000000207.

18.

Immunohistochemical detection of hepatocyte nuclear factor 1beta in ovarian and endometrial clear-cell adenocarcinomas and nonneoplastic endometrium.

Yamamoto S, Tsuda H, Aida S, Shimazaki H, Tamai S, Matsubara O.

Hum Pathol. 2007 Jul;38(7):1074-80. Epub 2007 Apr 18.

PMID:
17442376
19.

Hepatocyte nuclear factor-1β is not a specific marker of clear cell carcinoma in serous effusions.

Davidson B.

Cancer Cytopathol. 2014 Feb;122(2):153-8. doi: 10.1002/cncy.21353. Epub 2013 Sep 24.

20.

Loss of ARID1A/BAF250a expression in ovarian endometriosis and clear cell carcinoma.

Xiao W, Awadallah A, Xin W.

Int J Clin Exp Pathol. 2012;5(7):642-50. Epub 2012 Sep 5.

Supplemental Content

Support Center